Showing results (211-220 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|November 4, 2022
Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial dataTakashi Tsujii, Hitoshi Sakurai, Hiroyoshi Takeuchi, et al.
Neuropsychopharmacology Reports|September 19, 2022
Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin derivative improve β-amyloid peptide (25-35)-induced memory impairment in miceJunpei Takahashi, Yudai Ueta, Daisuke Yamada, et al.
Neuropsychopharmacology Reports|October 22, 2021
Transcranial magnetic stimulation modalities for psychiatric disorders: Publication trends from 1985 to 2019Yuki Matsuda, Ryuichi Yamazaki, Masahiro Shigeta, et al.
Neuropsychopharmacology Reports|February 19, 2022
Aripiprazole LAI two-injection start in a 16 year-old adolescent with schizophreniaVirginio Salvi, Cristina Appignanesi, Brodinela Marpepa, et al.
Neuropsychopharmacology Reports|April 27, 2019
Antidepressant amitriptyline-induced matrix metalloproteinase-9 activation is mediated by Src family tyrosine kinase, which leads to glial cell line-derived neurotrophic factor mRNA expression in rat astroglial cellsHiromi Abe, Naoto Kajitani, Mami Okada-Tsuchioka, et al.
Neuropsychopharmacology Reports|April 27, 2019
Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment designKazuto Oya, Kenji Sakuma, Satoru Esumi, et al.
Neuropsychopharmacology Reports|April 11, 2019
Changes of clinical symptoms in patients with new psychoactive substance (NPS)-related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addictionDaisuke Funada, Toshihiko Matsumoto, Yuko Tanibuchi, et al.
Neuropsychopharmacology Reports|January 28, 2022
Changes in median eminence of fatty acid-binding protein 3 in a mouse model of painDan Tachibana, Kazuo Nakamoto, Shogo Tokuyama
Neuropsychopharmacology Reports|April 12, 2022
COVID-19 vaccination did not improve employee mental health: A prospective study in an early phase of vaccination in JapanNatsu Sasaki, Reiko Kuroda, Kanami Tsuno, et al.
Neuropsychopharmacology Reports|October 3, 2018
Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory studyYaeko Yokoshima, Masahiko Sumitani, Daisuke Nishizawa, et al.
Pageof 66